RxDoctor Payments Data

Karen Stanley, DPM

Foot & Ankle Surgery · North Syracuse, NYNPI 1659358828

Payments from drug & device makers

$562in general payments, 2019–2025

Across 30 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$177
  • Trilliant Surgical LLC.$120
  • Rikco International, LLC$93
  • CSL Behring$55
  • Sandoz$44
  • Mimedx Group, Inc.$28
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$46983%
  • Education$9317%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.18$177
Trilliant Surgical LLC.1$120
Rikco International, LLC2$93
CSL Behring3$55
Sandoz2$44
Mimedx Group, Inc.1$28
AbbVie1$17
Melinta Therapeutics, LLC1$15
Merck1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$562 in reported general payments places this provider in the 25th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$184,413
Medicare patients
338
Services billed
2,706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.17$7,480
Allopurinol15$2,479
Gabapentin55$812
Ammonium Lactate39$687
Clotrimazole13$381
SsdSilver Sulfadiazine11$330
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$200
Cephalexin37$179
Meloxicam35$84
Cilostazol11$71
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$71

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in North Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →